Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 16 | 2023 | 159 | 7.120 |
Why?
|
| Tissue and Organ Procurement | 9 | 2024 | 40 | 4.710 |
Why?
|
| Tissue Donors | 12 | 2024 | 112 | 2.530 |
Why?
|
| Organ Transplantation | 4 | 2024 | 49 | 2.410 |
Why?
|
| Graft Survival | 6 | 2023 | 165 | 2.410 |
Why?
|
| Kidney Transplantation | 7 | 2023 | 189 | 2.360 |
Why?
|
| Postoperative Complications | 9 | 2023 | 1035 | 2.230 |
Why?
|
| Surgical Procedures, Operative | 3 | 2021 | 78 | 1.810 |
Why?
|
| Liver Neoplasms | 4 | 2023 | 352 | 1.280 |
Why?
|
| Pancreatic Neoplasms | 3 | 2016 | 234 | 1.270 |
Why?
|
| Liver | 5 | 2023 | 1226 | 1.250 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2023 | 203 | 1.220 |
Why?
|
| Humans | 50 | 2024 | 54304 | 1.050 |
Why?
|
| End Stage Liver Disease | 3 | 2023 | 44 | 0.940 |
Why?
|
| Transplants | 1 | 2023 | 18 | 0.930 |
Why?
|
| Developing Countries | 1 | 2023 | 51 | 0.890 |
Why?
|
| Hospitals, Low-Volume | 1 | 2021 | 23 | 0.810 |
Why?
|
| Hospitals, High-Volume | 1 | 2021 | 35 | 0.810 |
Why?
|
| Hepatitis B, Chronic | 1 | 2021 | 15 | 0.800 |
Why?
|
| Hepatitis B | 1 | 2021 | 27 | 0.790 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 84 | 0.750 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 325 | 0.730 |
Why?
|
| Respiratory Tract Diseases | 1 | 2020 | 29 | 0.730 |
Why?
|
| Models, Statistical | 1 | 2021 | 258 | 0.730 |
Why?
|
| Death | 4 | 2022 | 22 | 0.730 |
Why?
|
| Graft Rejection | 2 | 2022 | 161 | 0.720 |
Why?
|
| Graft vs Host Disease | 1 | 2020 | 84 | 0.720 |
Why?
|
| Vaccination | 1 | 2021 | 298 | 0.690 |
Why?
|
| Transplantation | 1 | 2018 | 17 | 0.650 |
Why?
|
| Economic Recession | 1 | 2018 | 8 | 0.650 |
Why?
|
| Middle Aged | 15 | 2022 | 13076 | 0.640 |
Why?
|
| Prospective Studies | 7 | 2023 | 2604 | 0.630 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 248 | 0.630 |
Why?
|
| Warm Ischemia | 1 | 2017 | 4 | 0.620 |
Why?
|
| Female | 21 | 2023 | 28457 | 0.610 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 318 | 0.610 |
Why?
|
| Calreticulin | 2 | 2016 | 12 | 0.600 |
Why?
|
| Internationality | 3 | 2021 | 49 | 0.590 |
Why?
|
| Electric Injuries | 1 | 2016 | 1 | 0.590 |
Why?
|
| Aged | 12 | 2022 | 10054 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 184 | 0.580 |
Why?
|
| Risk Assessment | 1 | 2021 | 1361 | 0.570 |
Why?
|
| Male | 21 | 2023 | 27335 | 0.570 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 192 | 0.570 |
Why?
|
| Quantum Dots | 1 | 2016 | 18 | 0.550 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 427 | 0.530 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2015 | 15 | 0.520 |
Why?
|
| Pancreatectomy | 1 | 2015 | 18 | 0.520 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 583 | 0.520 |
Why?
|
| Optical Imaging | 1 | 2015 | 30 | 0.520 |
Why?
|
| Antibodies, Neoplasm | 1 | 2015 | 35 | 0.510 |
Why?
|
| Cohort Studies | 5 | 2021 | 1547 | 0.510 |
Why?
|
| Pancreatic Cyst | 1 | 2014 | 13 | 0.500 |
Why?
|
| Retrospective Studies | 10 | 2023 | 6462 | 0.500 |
Why?
|
| Body Mass Index | 1 | 2017 | 705 | 0.490 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2014 | 35 | 0.490 |
Why?
|
| Precancerous Conditions | 1 | 2014 | 93 | 0.470 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2023 | 12 | 0.470 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 233 | 0.460 |
Why?
|
| Laparoscopy | 1 | 2015 | 186 | 0.440 |
Why?
|
| Pandemics | 2 | 2022 | 593 | 0.430 |
Why?
|
| United States | 6 | 2022 | 5204 | 0.420 |
Why?
|
| Patient Isolation | 1 | 2021 | 7 | 0.410 |
Why?
|
| Treatment Outcome | 8 | 2023 | 5609 | 0.410 |
Why?
|
| Adult | 10 | 2023 | 14189 | 0.400 |
Why?
|
| Time-to-Treatment | 2 | 2022 | 74 | 0.390 |
Why?
|
| Lung Diseases | 1 | 2021 | 86 | 0.380 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 75 | 0.370 |
Why?
|
| Young Adult | 5 | 2021 | 4313 | 0.370 |
Why?
|
| Preoperative Care | 1 | 2021 | 184 | 0.360 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 564 | 0.360 |
Why?
|
| Registries | 3 | 2022 | 552 | 0.340 |
Why?
|
| Bile Ducts | 2 | 2021 | 53 | 0.340 |
Why?
|
| Hospitals | 2 | 2023 | 188 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 487 | 0.310 |
Why?
|
| Adolescent | 5 | 2021 | 6896 | 0.300 |
Why?
|
| Obesity, Morbid | 2 | 2017 | 88 | 0.260 |
Why?
|
| Waiting Lists | 2 | 2023 | 49 | 0.260 |
Why?
|
| Brain Death | 2 | 2023 | 15 | 0.250 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2022 | 13 | 0.220 |
Why?
|
| Social Class | 1 | 2023 | 109 | 0.220 |
Why?
|
| Environment | 1 | 2023 | 102 | 0.220 |
Why?
|
| Burnout, Professional | 1 | 2023 | 57 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 181 | 0.210 |
Why?
|
| Length of Stay | 2 | 2023 | 683 | 0.210 |
Why?
|
| Pulmonary Embolism | 1 | 2023 | 107 | 0.200 |
Why?
|
| Preoperative Period | 1 | 2021 | 59 | 0.200 |
Why?
|
| Bayes Theorem | 1 | 2021 | 125 | 0.200 |
Why?
|
| Hospital Mortality | 2 | 2023 | 466 | 0.200 |
Why?
|
| Cholecystectomy | 1 | 2021 | 32 | 0.200 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 638 | 0.200 |
Why?
|
| Pneumonia | 1 | 2022 | 128 | 0.190 |
Why?
|
| Polymerase Chain Reaction | 1 | 2022 | 531 | 0.190 |
Why?
|
| Postoperative Care | 1 | 2021 | 121 | 0.190 |
Why?
|
| Health Personnel | 1 | 2023 | 247 | 0.190 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 270 | 0.180 |
Why?
|
| Nitriles | 1 | 2020 | 69 | 0.180 |
Why?
|
| Kidney | 2 | 2023 | 821 | 0.180 |
Why?
|
| Child | 3 | 2021 | 7372 | 0.180 |
Why?
|
| Off-Label Use | 1 | 2019 | 27 | 0.180 |
Why?
|
| Pyrazoles | 1 | 2020 | 110 | 0.180 |
Why?
|
| Embolism, Fat | 1 | 2019 | 4 | 0.180 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 130 | 0.180 |
Why?
|
| HIV Infections | 1 | 2023 | 394 | 0.170 |
Why?
|
| Comorbidity | 1 | 2021 | 666 | 0.170 |
Why?
|
| Sex Factors | 1 | 2022 | 766 | 0.170 |
Why?
|
| Emergency Medical Services | 1 | 2020 | 126 | 0.170 |
Why?
|
| Patient Discharge | 1 | 2022 | 352 | 0.170 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 218 | 0.170 |
Why?
|
| Pyrimidines | 1 | 2020 | 196 | 0.170 |
Why?
|
| Patient Readmission | 1 | 2021 | 242 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 127 | 0.170 |
Why?
|
| Greece | 1 | 2018 | 19 | 0.160 |
Why?
|
| Liver Diseases | 1 | 2019 | 87 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 330 | 0.160 |
Why?
|
| Medical Futility | 1 | 2018 | 12 | 0.160 |
Why?
|
| Dexamethasone | 1 | 2020 | 435 | 0.160 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1693 | 0.160 |
Why?
|
| Age Factors | 1 | 2022 | 1200 | 0.160 |
Why?
|
| Fatty Liver | 1 | 2019 | 129 | 0.160 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 303 | 0.160 |
Why?
|
| Gold | 2 | 2016 | 164 | 0.160 |
Why?
|
| Thinness | 1 | 2017 | 57 | 0.150 |
Why?
|
| Consensus | 1 | 2018 | 156 | 0.150 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 302 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 310 | 0.140 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2016 | 27 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 127 | 0.140 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2016 | 62 | 0.140 |
Why?
|
| Cricetinae | 1 | 2016 | 208 | 0.140 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 110 | 0.140 |
Why?
|
| Cause of Death | 1 | 2016 | 164 | 0.130 |
Why?
|
| Nanostructures | 1 | 2016 | 53 | 0.130 |
Why?
|
| Appetite Regulation | 1 | 2015 | 13 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 472 | 0.130 |
Why?
|
| Antibodies | 1 | 2016 | 178 | 0.130 |
Why?
|
| Gastric Bypass | 1 | 2015 | 22 | 0.130 |
Why?
|
| Survival Rate | 1 | 2017 | 954 | 0.130 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 3430 | 0.130 |
Why?
|
| Animals | 4 | 2023 | 14402 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 134 | 0.120 |
Why?
|
| Weight Loss | 1 | 2015 | 264 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2015 | 305 | 0.110 |
Why?
|
| Risk Factors | 1 | 2022 | 3934 | 0.110 |
Why?
|
| Neoadjuvant Therapy | 1 | 2023 | 125 | 0.110 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 1551 | 0.100 |
Why?
|
| Time | 1 | 2021 | 36 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2021 | 158 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2023 | 264 | 0.100 |
Why?
|
| Age Distribution | 1 | 2021 | 198 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2023 | 805 | 0.100 |
Why?
|
| Rotator Cuff | 1 | 2000 | 23 | 0.090 |
Why?
|
| Living Donors | 1 | 2023 | 25 | 0.060 |
Why?
|
| Interleukins | 1 | 2023 | 39 | 0.060 |
Why?
|
| Organ Preservation | 1 | 2023 | 16 | 0.060 |
Why?
|
| Perfusion | 1 | 2023 | 41 | 0.060 |
Why?
|
| Delayed Graft Function | 1 | 2022 | 11 | 0.060 |
Why?
|
| alpha-Fetoproteins | 1 | 2022 | 15 | 0.060 |
Why?
|
| Cold Ischemia | 1 | 2022 | 11 | 0.060 |
Why?
|
| Colectomy | 1 | 2022 | 33 | 0.050 |
Why?
|
| Pancreas | 1 | 2022 | 80 | 0.050 |
Why?
|
| Creatinine | 1 | 2022 | 169 | 0.050 |
Why?
|
| Infant | 1 | 2021 | 3832 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 149 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2021 | 4161 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2021 | 46 | 0.050 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2021 | 24 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2022 | 245 | 0.050 |
Why?
|
| Reperfusion | 1 | 2019 | 15 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2023 | 1083 | 0.040 |
Why?
|
| Reoperation | 1 | 2021 | 453 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2019 | 225 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 645 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2019 | 117 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 1083 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 693 | 0.040 |
Why?
|
| Clergy | 1 | 2016 | 24 | 0.040 |
Why?
|
| Fluorescence | 1 | 2016 | 53 | 0.040 |
Why?
|
| Time Factors | 1 | 2022 | 3207 | 0.030 |
Why?
|
| Mice | 1 | 2023 | 6428 | 0.030 |
Why?
|
| Shoulder Dislocation | 1 | 2000 | 6 | 0.020 |
Why?
|